/

European Healthcare Acquisition & Growth Company B.V.

EHCS NA

EHCS NAEuropean Healthcare Acquisition & Growth Company B.V.

FIGI: BBG013K77435

- -

Upgrade to Unlock Non-US CompaniesTo view real-time data and analysis of companies outside of the United States, upgrade your account to our premium subscription.

Upgrade

European Healthcare Acquisition & Growth Company B.V.

EHCS:NA

(EN AMSTERDAM)

Recent

price

- -

P/E

ratio

- -

div

yld

- -

ROIC.AI

Legends:

Stock price

- -

Beta (1.0 Market)

% total return 10/01

Stock

S&P500

YTD

- -

2021

2022

TTM

USD

- -

12,345

- -

12,345

- -

12,345

- -

12,345

- -

12,345

- -

12,345

- -

12,345

- -

12,345

- -

12,345

- -

12,345

- -

12,345

- -

12,345

- -

12,345

- -

12,345

- -

12,345

- -

12,345

- -

12,345

- -

12,345

- -

12,345

Capital Structure

USD

•

in mil. unless spec.

Jun'21

Jun'22

Dec'22

ST Debt

12,345

LT Borrowings

12,345

LT Finance Leases

12,345

Preferred Equity and Hybrid Capital

12,345

Shares Outstanding

12,345

Market Capitalization

12,345

Working Capital

USD

•

in mil. unless spec.

Jun'21

Jun'22

Dec'22

Total Current Assets

12,345

Cash, Cash Equivalents & STI

12,345

Accounts Receivable, Net

12,345

Inventories

12,345

Total Current Liabilities

12,345

Payables & Accruals

12,345

ST Debt

12,345

Deferred Revenue

12,345

Growth Rates

USD

•

in mil. unless spec.

(avg. rate of change)

10 years

5 years

1 year

Sales/Revenue/Turnover

12,345

Net Income, GAAP

12,345

Free Cash Flow

12,345

Total Cash Common Dividend

12,345

Total Equity

12,345

Quarterly Revenue

USD

•

in mil. unless spec.

Year

2020

- -

2021

- -

12,345

2022

12,345

- -

12,345

Quarterly Earnings Per Share

USD

•

in mil. unless spec.

Year

2020

- -

2021

- -

12,345

2022

12,345

- -

12,345

Quarterly Dividends Per Share

USD

•

in mil. unless spec.

Year

2020

- -

2021

- -

12,345

2022

12,345

- -

12,345

Business: European Healthcare Acquisition & Growth Company B.V. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more companies or businesses. It also focuses on acquiring companies or businesses in the healthcare sector with a focus on biotechnology and specialty pharma, pharma services, medical technology and medical devices, diagnostic and lab services, and bioinformatics, as well as life science tools subsectors in Europe. The company was incorporated in 2021 and is based in Munich, Germany.

- -

2021

2022

TTM

USD

- -

12,345

- -

12,345

- -

12,345

- -

12,345

- -

12,345

- -

12,345

- -

12,345

- -

12,345

- -

12,345

- -

12,345

- -

12,345

- -

12,345

- -

12,345

- -

12,345

- -

12,345

- -

12,345

- -

12,345

- -

12,345

- -

12,345